Mitral Valve Regurgitation Clinical Trial
Official title:
Mitigating Cardiac Inflammation and Oxidative Stress in Atrial Myocardium Via Short-term Lovaza Treatment Prior to Surgery
In the absence of treatment, severe mitral valve regurgitation (MR) results in left atrium (LA) dilatation and hypertrophy, followed ultimately by left ventricular dysfunction and heart failure. One promising intervention for the prevention of the deleterious effects of pressure overload-induced cardiac hypertrophy and heart failure is dietary supplementation with n-3 polyunsaturated fatty acids (PUFAs). However, the molecular targets and mechanisms by which n-3 PUFAs exert their effects are not completely defined. A possible target of n-3 PUFAs is the mitochondrial membrane which has broad implications given that mitochondrial dysfunction and altered metabolism have been associated with cardiac hypertrophy and heart failure. The investigators have recently identified significant mitochondrial dysfunction in the LA of patients with severe MR, as compared to their non-hypertrophied right atrium (RA). However, the investigators have not addressed the possibility that intervention with purified n-3 PUFAs (Lovaza) could improve mitochondrial function. From a mechanistic perspective, the investigators have observed in vitro that n-3 PUFAs accumulate predominately into the mitochondrial membrane of cardiomyocytes where the investigators believe they exert their effects on the biophysical organization of the membrane. Therefore, the CENTRAL HYPOTHESIS is that administering Lovaza to patients with severe MR will reduce apoptosis and improve mitochondrial function in LA (Aim 1). This change in mitochondrial function will be driven by significant biochemical and biophysical remodeling of the mitochondrial membrane (Aim 2).
n/a
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02520310 -
AVJ-514 Japan Trial
|
N/A | |
Not yet recruiting |
NCT06465745 -
AltaValve Pivotal Trial
|
N/A | |
Completed |
NCT02355418 -
The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
|
||
Recruiting |
NCT04577248 -
The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
|
||
Recruiting |
NCT03242642 -
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
|
N/A | |
Recruiting |
NCT02961647 -
Hemodynamic Stress Test in Severe Mitral Regurgitation (HEMI)
|
N/A | |
Active, not recruiting |
NCT02302872 -
Treatment of Heart Failure and Associated Functional Mitral Valve Regurgitation
|
N/A | |
Completed |
NCT01777815 -
Safety and Performance Study of the NeoChord Device
|
N/A | |
Withdrawn |
NCT00428103 -
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
|
N/A | |
Completed |
NCT04351984 -
Transcatheter Mitral Valvuloplasty Pilot Study
|
||
Withdrawn |
NCT02722551 -
CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02321514 -
Expanded Clinical Study of the Tendyne Mitral Valve System
|
N/A | |
Recruiting |
NCT02245763 -
STS/ACC TVT Registry Mitral Module
|
||
Active, not recruiting |
NCT01740583 -
Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation
|
N/A | |
Completed |
NCT00800046 -
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
|
N/A | |
Completed |
NCT00415701 -
Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT03908983 -
OPtimisation of Surgical Repair for Treating Insufficiency of the MItral Valve - Safety and Effectiveness Evaluation
|
N/A | |
Active, not recruiting |
NCT04818502 -
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation
|
||
Terminated |
NCT03285724 -
Safety and Performance Study of the Harpoon Mitral Valve Repair System
|
N/A | |
Recruiting |
NCT04195984 -
Mi-thos® Transcatheter Mitral Valve Replacement Study
|
N/A |